Low-Dose Image-Guided Pediatric CNS Radiation Therapy: Final Analysis From a Prospective Low-Dose Cone-Beam CT Protocol From a Multinational Pediatrics Consortium.


Journal

Technology in cancer research & treatment
ISSN: 1533-0338
Titre abrégé: Technol Cancer Res Treat
Pays: United States
ID NLM: 101140941

Informations de publication

Date de publication:
Historique:
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 21 11 2020
Statut: ppublish

Résumé

Lower-dose cone-beam computed tomography protocols for image-guided radiotherapy may permit target localization while minimizing radiation exposure. We prospectively evaluated a lower-dose cone-beam protocol for central nervous system image-guided radiotherapy across a multinational pediatrics consortium. Seven institutions prospectively employed a lower-dose cone-beam computed tomography central nervous system protocol (weighted average dose 0.7 mGy) for patients ≤21 years. Treatment table shifts between setup with surface lasers versus cone-beam computed tomography were used to approximate setup accuracy, and vector magnitudes for these shifts were calculated. Setup group mean, interpatient, interinstitution, and random error were estimated, and clinical factors were compared by mixed linear modeling. Among 96 patients, with 2179 pretreatment cone-beam computed tomography acquisitions, median age was 9 years (1-20). Setup parameters were 3.13, 3.02, 1.64, and 1.48 mm for vector magnitude group mean, interpatient, interinstitution, and random error, respectively. On multivariable analysis, there were no significant differences in mean vector magnitude by age, gender, performance status, target location, extent of resection, chemotherapy, or steroid or anesthesia use. Providers rated >99% of images as adequate or better for target localization. A lower-dose cone-beam computed tomography protocol demonstrated table shift vector magnitude that approximate clinical target volume/planning target volume expansions used in central nervous system radiotherapy. There were no significant clinical predictors of setup accuracy identified, supporting use of this lower-dose cone-beam computed tomography protocol across a diverse pediatric population with brain tumors.

Sections du résumé

BACKGROUND
Lower-dose cone-beam computed tomography protocols for image-guided radiotherapy may permit target localization while minimizing radiation exposure. We prospectively evaluated a lower-dose cone-beam protocol for central nervous system image-guided radiotherapy across a multinational pediatrics consortium.
METHODS
Seven institutions prospectively employed a lower-dose cone-beam computed tomography central nervous system protocol (weighted average dose 0.7 mGy) for patients ≤21 years. Treatment table shifts between setup with surface lasers versus cone-beam computed tomography were used to approximate setup accuracy, and vector magnitudes for these shifts were calculated. Setup group mean, interpatient, interinstitution, and random error were estimated, and clinical factors were compared by mixed linear modeling.
RESULTS
Among 96 patients, with 2179 pretreatment cone-beam computed tomography acquisitions, median age was 9 years (1-20). Setup parameters were 3.13, 3.02, 1.64, and 1.48 mm for vector magnitude group mean, interpatient, interinstitution, and random error, respectively. On multivariable analysis, there were no significant differences in mean vector magnitude by age, gender, performance status, target location, extent of resection, chemotherapy, or steroid or anesthesia use. Providers rated >99% of images as adequate or better for target localization.
CONCLUSIONS
A lower-dose cone-beam computed tomography protocol demonstrated table shift vector magnitude that approximate clinical target volume/planning target volume expansions used in central nervous system radiotherapy. There were no significant clinical predictors of setup accuracy identified, supporting use of this lower-dose cone-beam computed tomography protocol across a diverse pediatric population with brain tumors.

Identifiants

pubmed: 32329413
doi: 10.1177/1533033820920650
pmc: PMC7225835
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1533033820920650

Références

J Clin Oncol. 2007 Mar 10;25(8):938-46
pubmed: 17350942
Med Phys. 2008 Feb;35(2):480-6
pubmed: 18383668
J Med Phys. 2012 Oct;37(4):174-82
pubmed: 23293448
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):281-90
pubmed: 20951506
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):294-301
pubmed: 17707284
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1568-75
pubmed: 17126213
Pract Radiat Oncol. 2014 Sep-Oct;4(5):336-341
pubmed: 25194103
J Appl Clin Med Phys. 2018 Jan;19(1):174-183
pubmed: 29265684
Radiother Oncol. 2007 Dec;85(3):418-23
pubmed: 18023491
Med Phys. 2020 Feb;47(2):467-479
pubmed: 31808950
Radiother Oncol. 2008 Jan;86(1):4-13
pubmed: 18083259
Expert Rev Anticancer Ther. 2007 Jan;7(1):89-103
pubmed: 17187523
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):926-33
pubmed: 18514784
Neural Plast. 2013;2013:698528
pubmed: 23691370
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):610-7
pubmed: 19147025
Med Phys. 2007 Oct;34(10):4041-63
pubmed: 17985650
Oncologist. 1999;4(1):45-54
pubmed: 10337370
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):625-34
pubmed: 16343802
Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):60-5
pubmed: 11641018
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1330-7
pubmed: 20643515
Anticancer Res. 2010 Jan;30(1):227-31
pubmed: 20150640
Ann Neurol. 1978 Oct;4(4):345-56
pubmed: 727739

Auteurs

Sara R Alcorn (SR)

The Johns Hopkins Hospital, Baltimore, MD, USA.

Xian Chiong Zhou (XC)

The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Casey Bojechko (C)

University of Washington, Seattle, WA, USA.

Rodrigo A Rubo (RA)

Centro Infantil Boldrini, São Paulo e Região, Brazil.

Michael J Chen (MJ)

Grupo de Apoio ao Adolescente e à Criança com Câncer, São Paulo, Brazil.

Karin Dieckmann (K)

Universität Klinik Für Strahlentherapie und Strahlenbiologie, Vienna, Austria.

Ralph P Ermoian (RP)

University of Washington, Seattle, WA, USA.

Eric C Ford (EC)

University of Washington, Seattle, WA, USA.

Daria Kobyzeva (D)

Federal Scientific Clinical Center of Children's Hematology, Oncology and Immunology, Moscow, Russia.

Shannon M MacDonald (SM)

Massachusetts General Hospital, Boston, MA, USA.

Todd R McNutt (TR)

The Johns Hopkins Hospital, Baltimore, MD, USA.

Alexey Nechesnyuk (A)

Federal Scientific Clinical Center of Children's Hematology, Oncology and Immunology, Moscow, Russia.

Kristina Nilsson (K)

Uppsala University Hospital, Uppsala, Sweden.

Hakan Sjostrand (H)

Uppsala University Hospital, Uppsala, Sweden.

Koren S Smith (KS)

The Johns Hopkins Hospital, Baltimore, MD, USA.

Markus Stock (M)

Universität Klinik Für Strahlentherapie und Strahlenbiologie, Vienna, Austria.

Erik J Tryggestad (EJ)

Mayo Clinic, Rochester, MN, USA.

Rosangela C Villar (RC)

Centro Infantil Boldrini, São Paulo e Região, Brazil.

Brian A Winey (BA)

Massachusetts General Hospital, Boston, MA, USA.

Stephanie A Terezakis (SA)

Department of Radiation Oncology and Molecular Radiation Sciences, University of Minnesota, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH